Evidence map›Paper›PMID 28943249›Full record

ArticleNeuroscience2017

Effects of crenolanib, a nonselective inhibitor of PDGFR, in a mouse model of transient middle cerebral artery occlusion.

Jianping Wang, Xiaojie Fu, Di Zhang, Lie Yu, Zhengfang Lu, Yufeng Gao, Xianliang Liu, Jiang Man, Sijia Li, Nan Li and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Cuproptosis-associated genesFrontiers in immunology · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Jianping WangDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address: wjpwfy666@126.com.
Xiaojie FuDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Di ZhangDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Lie YuDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Zhengfang LuDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yufeng GaoDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xianliang LiuDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Jiang ManDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Sijia LiDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Nan LiDepartment of Neurology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Menghan WangDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xi LiuDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xuemei ChenDepartment of Anatomy, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
Weidong ZangDepartment of Anatomy, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
Qingwu YangDepartment of Neurology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Jian WangDepartment of Anatomy, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China; Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD, USA. Electronic address: jwang79@jhmi.edu.
Fifth Affiliated Hospital of Zhengzhou University · CNZhengzhou University · CNFirst Affiliated Hospital of Zhengzhou University · CNArmy Medical University · CNSecond Affiliated Hospital of Zhengzhou University · CN

Funding

Neuroprotective effect of flavanol (-) epicatechin after intracerebral hemorrhageR01AT007317 · NCCIH · JOHNS HOPKINS UNIVERSITY · PI WANG, JIAN · 2012 to 2016
$2.0M
PGE2 EP1 and EP3 receptors as therapeutic targets in intracerebral hemorrhageR01NS078026 · NINDS · JOHNS HOPKINS UNIVERSITY · PI WANG, JIAN · 2012 to 2016
$1.8M
Microglia/macrophage polarization after intracerebral hemorrhageR56NS096549 · NINDS · JOHNS HOPKINS UNIVERSITY · PI WANG, JIAN · 2017 to 2017
$488k
Depression after Intracerebral Hemorrhage: Role of Nrf2R21NS101614 · NINDS · JOHNS HOPKINS UNIVERSITY · PI WANG, JIAN · 2017 to 2018
$450k
NCCIH NIH HHS R01 AT007317NINDS NIH HHS R01 NS078026NINDS NIH HHS R21 NS101614NINDS NIH HHS R56 NS096549
6 · The paper itself

Abstract

Neurogenesis in the subventricular zone (SVZ) plays a vital role in neurologic recovery after stroke. However, only a small fraction of newly generated neuroblasts from the SVZ will survive long-term. Successful migration and survival of neuroblasts requires angiogenesis, lesion-derived chemo-attractants, and appropriate local microenvironments, which are partly regulated by the platelet-derived growth factor receptor (PDGFR) signaling pathway. In this study, we investigated the effects of PDGFR inhibition in a mouse model of transient middle cerebral artery occlusion (MCAO). We blocked the pathway using a nonselective PDGFR inhibitor, crenolanib, during the acute post-MCAO phase (days 1-3) or during the sub-acute phase (days 7-9). Downregulating the PDGFR signaling pathway with crenolanib from day 1 to day 3 after MCAO significantly decreased the migration of neuroblasts from the SVZ to the peri-infarct region, decreased angiogenesis, and lowered expression of vascular endothelial growth factor, stromal cell-derived factor-1, and monocyte chemotactic protein-1. Downregulation of the PDGFR signaling pathway on days 7-9 with crenolanib significantly increased apoptosis of the neuroblasts that had migrated to the peri-infarct region, increased the number of activated microglia, and decreased the expression of brain-derived neurotrophic factor, neurotrophin-3, and interleukin-10. Crenolanib treatment increased the apoptosis of pericytes and decreased the pericyte/vascular coverage, but had no effects on apoptosis of astrocytes. We conclude that the PDGFR signaling pathway plays a vital role in the SVZ neurogenesis after stroke. It can also affect angiogenesis, lesion-derived chemo-attractants, and the local microenvironment, which are all important to stroke-induced neurogenesis.

Indexed as

Infarction, Middle Cerebral ArteryAnimalsBenzimidazolesDisease Models, AnimalLateral VentriclesMaleMiceMice, Inbred C57BLNeurogenesisPiperidinesReceptors, Platelet-Derived Growth FactorSignal TransductionBenzimidazolescrenolanibPiperidinesReceptors, Platelet-Derived Growth FactorneuroblastsneurogenesisPDGFRstrokesubventricular zone

Identifiers

PMID28943249
PMCPMC5653447
OpenAlexW2760496522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.